Camtek Ltd. filings document foreign-issuer current reports on operating results, customer orders, investor presentations, material agreements, capital structure and governance. The company’s Form 6-K disclosures include financial-result releases, order announcements for semiconductor inspection and metrology systems, and operating and financial review materials.
Camtek’s regulatory record also covers capital-structure activity, including convertible senior notes due 2030, and risk disclosures tied to semiconductor capital spending, demand for HPC, HBM and chiplet devices, global trade and export restrictions, and geographic concentration in Asia Pacific markets. These filings describe the company as a Nasdaq- and TASE-listed supplier serving IDMs, OSATs and foundries.
Camtek Ltd. investor Yael Andorn filed a Form 144 notice for a proposed sale of 3,176 ordinary shares of Camtek Ltd., to be handled through Oppenheimer & Co. Inc. on or after 08/14/2026 on Nasdaq. The shares are described as having been acquired upon the exercise of employee stock options, with a cash payment made upon exercise of those options.
The filing also lists securities sold during the past three months, showing that on 08/13/2026 Andorn sold 2,356 ordinary shares for an aggregate amount of 406,065.92. The Form 144 serves as an advance notice of the potential future sale of restricted or control shares.
Camtek Ltd. filed a notice of proposed sale of 6,250 Ordinary Shares through Oppenheimer & Co. Inc. on Nasdaq, with an aggregate market value of $1,088,750.00, based on 45,828,133 Ordinary Shares outstanding as of the notice. The filing also lists prior issuances of Ordinary Shares upon vesting of RSUs on 01/24/2023 (15,145 shares), 02/16/2023 (10,097 shares), and 01/16/2024 (19,878 shares), all issued for no cash consideration.
Camtek Ltd has a notice to sell 2,356 Ordinary Shares on Nasdaq through Oppenheimer & Co. Inc., with the entry dated 08/13/2026. The shares to be sold were acquired from equity compensation: 1,082 shares issued upon vesting of RSUs on 12/21/2023, 394 shares issued upon vesting of RSUs on 09/25/2024, and 880 shares acquired upon exercise of employee stock options on 08/13/2026. The RSU shares were received for no cash consideration, while the option shares required a cash payment upon exercise.
A shareholder of Camtek Ltd. filed to potentially sell 6,387 Ordinary Shares, with an aggregate market value of $1,112,615.40, on or after August 13, 2026 through Oppenheimer & Co. Inc. on Nasdaq. The filing also lists prior Ordinary Shares issued upon vesting of RSUs on January 16, 2024 (12,701 shares) and April 1, 2025 (2,872 and 1,701 shares) for no cash consideration.
CAMTEK LTD vice president of HR, Orit Geva-Dvash, reported a sale of 415 Ordinary Shares of CAMT on 2026-08-12 at $174.0623 per share in an open-market or private transaction. Following this sale, she directly holds 5,713 Ordinary Shares, a balance that includes one additional share previously omitted from her Form 3 due to a rounding error. The filing does not indicate that this trade was made under a Rule 10b5-1 trading plan.
Camtek Ltd (CAMT) director Aviram Lior reported selling a total of 6,694 ordinary shares in four open-market transactions on August 11–12, 2026, at prices between 162.0000 and 175.0000 per share. The Rule 10b5-1 checkbox was not selected. A footnote explains that one additional share had been omitted from a prior Form 3 due to a rounding error.
Camtek Ltd. Chief Financial Officer Moshe Eisenberg reported open-market sales of Camtek ordinary shares. On 2026-08-12 he sold 645 shares at $172.6717 per share. On 2026-08-11 he sold 3,759 shares at a weighted average price of $160.0561, in multiple trades between $160.00 and $160.5651 per share.
Camtek Ltd is the issuer on an amended Rule 144 notice covering ordinary shares to be sold through Oppenheimer & Co. Inc. The notice lists shares that were issued upon vesting of RSUs on several dates, including tranches of 9,738, 5,564, 2,206, 7,420 and 1,307 shares, all received for no cash consideration. The ordinary shares are shown as trading on Nasdaq with a reference date of 08/11/2026.
Camtek Ltd filed a notice of proposed sale of 415 ordinary shares under Rule 144. The shares were originally issued upon vesting of RSUs on 04/01/2025 for no cash consideration. Oppenheimer & Co. Inc. is listed as the broker, with an aggregate market value of $68,230.15 for the planned sale and 45,828,133 ordinary shares outstanding. The approximate sale date is 08/12/2026 on Nasdaq.
Lior Aviram filed a Form 144 in connection with ordinary shares of Camtek Ltd.. The notice covers a proposed sale of 3,347 ordinary shares of Camtek through Oppenheimer & Co. Inc., listed on Nasdaq, with an aggregate market value of $583,047.40. The shares were issued on 06/01/2026 upon vesting of RSUs for no cash consideration. The filing also notes that 3,347 ordinary shares were sold on 08/11/2026 for $545,530.00.